Table of Contents
Research & Development
| Yamanouchi and Pfizer Streamline Partnership for Japan | Abstract pdf |
| Business Review Editor |
| MorphoSys and Novartis Sign Antibody Agreement | Abstract pdf |
| Business Review Editor |
Licensing
| CuraGen Licenses TopoTarget’s HDAC Inhibitor | Abstract pdf |
| Business Review Editor |
Mergers & Acquisitions
| UCB Tenders US$2.7 B Offer to Acquire Celltech | Abstract pdf |
| Business Review Editor |
Company Profile
| Sereno SA | Abstract pdf |
| Business Review Editor |
Distribution & Marketing
| Abbott Acquires Remaining Rights to Trandolapril from Aventis | Abstract pdf |
| Business Review Editor |
This work is licensed under a Creative Commons Attribution 3.0 License.